Lab Automation

Symposium

velixX at Lab Automation Symposium

The second Festo Lab Automation Symposium was organised at Esslingen last week (on Thursday, 30 October 2014) in which velixX also participated.

At the symposium, Festo AG & Co. KG had invited several health industry experts from across the globe, to share their views and experiences on important topics affecting the health industry – such as increasing cost pressure and the consequently rising demand for rapid implementation of new molecular diagnostics strategies. It has led to a greater need for more efficient automation concepts and for quickly bringing them to the market. This constituted the key focus of the symposium.

Well known health experts from around the globe (including USA, UK, Austria, Germany, Italy) showcased their views and experiences in the field of laboratory process automation and demonstrated various approaches to solutions at the symposium.

The event was attended by members of velixX staff and Mr. Manfred Augstein (CEO, velixX GmbH). It provided an excellent opportunity for highly informative discussions on the topic and also for connecting with industry partners. There were exciting presentations on automation and optimisation in the field of Biomarkers, Biobanking, Personalised Medicine, actual practice and future applications during the event.

Insightful presentations and panel discussions in the morning were followed by a refreshing afternoon session where attendees could choose between a guided tour of the Festo factory, a seminar on Nano- and Bio-Engineering, or a visit to the World Café for further discussions on the topic of Personalised Medicine and Companion Diagnostics. An exhibition of current and future automation concepts from the health industry was also organised at the event, offering many other interesting first-hand insights in the field of lab automation.

Contact

Ansprechpartner: Manfred Augstein
Wildbader Straße 7
68239 Mannheim
Telefon: 0621 / 437 08 001
E-Mail: mail@velixx.com

Copyright 2018 © Velixx | Imprint | Privacy Policy | Deutsche Version